Intranasal SB-705498 in Non-allergic Rhinitis Patients

NCT01439308 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis

Interventions

DRUG: Placebo
DRUG: SB-705498

Sponsor

GlaxoSmithKline